Parkman Healthcare Partners’s Lyra Therapeutics LYRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,845	Closed	-$3.99M	–	103
2024 Q1	$3.99M	Sell	12,845 -2,253	-15%	-$701K	0.49%	65
2023 Q4	$3.96M	Buy	15,098 +2,597	+21%	+$680K	0.56%	58
2023 Q3	$2.44M	Buy	12,501 +501	+4%	+$97.9K	0.45%	65
2023 Q2	$2.47M	Buy	+12,000	New	+$2.47M	0.43%	66